|
| |
BPI’s International Impact Honored by PRECARN
Waterloo, ON, Jun 1, 2007: Biomedical Photometrics Inc. (BPI), the
leading panoramic laser scanning confocal imaging systems manufacturer for drug
discovery, pathology and genomics research, announced today that the company has
been named by PRECARN Incorporated as recipient of the 2007 Anthony T. Eyton
Award for International Impact. The Award was given to BPI based on
commercialization and international sales of innovative fluorescence imaging
systems that resulted from the PRECARN Biochips project. Participants in the
Biochips project included BPI (Project Manager), ATS Automation Tooling Systems
Inc., National Research Council of Canada, Robarts Research Institute, and the
University of Waterloo.
The Award was presented to BPI this week at the PRECARN Members Banquet in
Montreal, Canada. “We are very pleased to receive the 2007 Anthony T. Eyton
Award for International Impact” said BPI’s CEO, A.E. (Ted) Dixon. “This award
validates BPI’s capabilities in developing and commercializing a technology
platform and successfully selling the resulting product into global markets.”
About Biomedical Photometrics Inc.
Biomedical Photometrics Inc. (BPI) develops, manufactures and markets
multifunctional scanning laser imaging systems that combine patented panoramic
fluorescence confocal technology with automated functionality. BPI DNAscope and
TISSUEscope products are used around the world by leading medical research,
pharmaceutical, biotechnology, and government laboratories to gain new insight
into such varied applications as tissue regeneration, efficacy of experimental
drugs, toxicological changes, 3-D histology, custom microarray development, and
dynamic scanning of integrated fluidic circuits (IFCs). Complete specifications
for products can be found at www.confocal.com
.
About PRECARN
PRECARN is an independent not-for-profit company that supports the
pre-commercial development of leading-edge technologies. PRECARN works with
Canadian companies who are seeking to commercialize their new ideas to get an
edge in global markets.
Unlike other research funding programs, PRECARN uses a collaborative model that
includes a developer, a customer and an academic research partner in every
project. This collaboration accelerates development, reduces risk and shares the
cost of the R&D. PRECARN provides access to an extensive national network of
world-class researchers, innovative companies, and sources of funding. For more
information, visit http://www.precarn.ca
Contact: Glenn Smith
Phone: (519) 886-9013 x38
Email: gsmith@confocal.com
Fax: (519) 886-5300 | |
|
